U.S., Jan. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07329673) titled 'An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms' on Dec. 11, 2025.
Brief Summary: The purpose of this study is to evaluate QbMobile's ability to collect objective data to identify specific symptom profiles in differential diagnoses (ASD, MDD, Bipolar Disorder and Anxiety Disorder) that are common with ADHD.
Study Start Date: Jan., 2026
Study Type: OBSERVATIONAL
Condition:
Bi-Polar Disorder
Autism Spectrum Disorder (ASD)
Major Depression Disorders
Separation Anxiety Disorder
Social Anxiety Disorder
Generalized Anxiety Disorder (GAD)
Intervention:
DEVICE: Digital software app...